Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Services-Hospitals · Sunrise, FL · filing with the SEC since 1996
Grade4.1
◀ Past 3.1● Present 3.8▶ Future 5.6
Who owns Pediatrix Medical Group, Inc.
As filed with the SECHolders of 5% or more
4
Blackrock, Inc. holds 14.6% of Common Stock, as its SCHEDULE 13G/A filed Jul 17, 2025 says.
Directors and officers
13
report now, of 38 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 17, 2025 · Common Stock
Vanguard Portfolio Management
SCHEDULE 13G · filed Sep 3, 2026 · Common Stock
Vanguard Capital Management
SCHEDULE 13G · filed Sep 3, 2026 · Common Stock
Dimensional Fund Advisors LP
SCHEDULE 13G · filed Jul 14, 2026 · Common Stock
Rubric Capital Management LP
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock, $0.01 par value · reported falling below 5%
AllianceBernstein L.P.
SCHEDULE 13G/A · filed Jun 3, 2025 · Common Stock · reported falling below 5%, from 8% in May 14, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Sep 3, 2026 · Common Stock · reported falling below 5%
What MD reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 1 country, from the list filed with the 10-K filed Feb 19, 2026.
Insider tradesForm 4
4sales
0purchases
0sales on a scheduled plan
4people selling
$1.8Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 38 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Weis Shirley A | director | 1 | $900,000 | 0 | 0 | $0 |
| Ordan Mark S | Chief Executive Officer | 1 | $500,000 | 0 | 0 | $0 |
| Linynsky Laura A | director | 1 | $200,000 | 0 | 0 | $0 |
| Rucker Michael A. | director | 1 | $200,000 | 0 | 0 | $0 |